Capitalink Ltd. Decreases Stake in Quantum X Labs Inc. to 4.99%

2026-05-15SEC Filing SCHEDULE 13G/A (0001213900-26-057771)

Capitalink Ltd. has filed an amendment to its Schedule 13G (Amendment No. 1) regarding its holdings in Quantum X Labs Inc. (VBIX). As of the event date on March 31, 2026, the reporting person disclosed beneficial ownership of 667,034 shares of common stock, representing 4.99% of the company. This reflects a decrease from the previously reported position of 672,007 shares (5.04%). The total beneficial ownership includes 629,034 shares held directly and 38,000 shares issuable upon the exercise of warrants exercisable within 60 days. Notably, the reporting person holds an additional warrant for 44,283 shares that cannot currently be exercised due to a 4.99% blocker provision. By crossing below the 5% threshold, Capitalink Ltd. has indicated that it now owns 5% or less of the class of securities. The filing specifies that the shares were not acquired for the purpose of changing or influencing the control of the issuer. Capitalink Ltd. is based in Israel and maintains sole voting and dispositive power over the reported shares.